← Back to Bills
HR 9828118th CongressFailed / ExpiredHouse

End the Vaccine Carveout Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Feb 19, 2025
Latest Action Date
Sep 25, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The End the Vaccine Carveout Act (H.R. 9828) was a bill introduced in the 118th Congress aimed at addressing a specific exemption or 'carveout' related to vaccines. The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. There is no official summary or full text available to provide detailed provisions or objectives of the bill. The policy area is health, indicating the bill relates to public health or vaccine policy.

Bottom Line

H.R. 9828 sought to eliminate a vaccine-related exemption but did not progress beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce.
  • The bill's title suggests it aimed to remove a vaccine-related exemption or 'carveout,' though no detailed summary or text is available.
  • The bill status is recorded as failed or expired, indicating it did not become law.
Who Benefits?

['Potentially public health agencies and the general public if the bill intended to close vaccine exemptions, though specifics are unavailable.', "Healthcare providers and organizations involved in vaccination programs may be affected depending on the carveout's nature."]

Potential Concerns

['Lack of available full text and summary limits understanding of implementation requirements and enforcement mechanisms.', 'Without detailed provisions, potential cost implications, authority changes, or oversight responsibilities cannot be assessed.', 'The failure to advance suggests possible legislative or policy challenges.']

Political Context

The bill was introduced during the 118th Congress and referred to a relevant committee but did not advance, reflecting either limited legislative support or prioritization. The absence of a summary or text in the official record limits insight into the broader policy debate or stakeholder positions.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced vaccine policy enforcement or exemption rules, potentially affecting public health outcomes.', 'The failure of the bill to advance may maintain the status quo regarding vaccine exemptions or carveouts.']

GovScope Watchdog Notes

The absence of an official summary and full bill text limits transparency and public oversight. Monitoring bills with incomplete documentation is important to ensure accountability. The bill's failure to progress highlights the need to track legislative movement to understand policy priorities and barriers.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready